32 results
DEFM14A
SQZB
SQZ Biotechnologies Co
23 Jan 24
Proxy related to merger
4:31pm
decrees, corporate integrity agreements, debarment or exclusion from federal healthcare programs;
mandated modification of promotional materials … and labeling and the issuance of corrective information;
the issuance of safety alerts, Dear Healthcare Provider letters, press releases and other
PREM14A
SQZB
SQZ Biotechnologies Co
12 Jan 24
Preliminary proxy related to merger
8:57am
or export of products;
consent decrees, corporate integrity agreements, debarment or exclusion from federal healthcare programs;
mandated modification … of promotional materials and labeling and the issuance of corrective information;
the issuance of safety alerts, Dear Healthcare Provider letters, press
8-K
EX-2.1
SQZB
SQZ Biotechnologies Co
22 Dec 23
Entry into a Material Definitive Agreement
5:18pm
with Seller or providing services to Seller, is and are not and have not been debarred, excluded or suspended from any federal healthcare program … (as defined in 42 U.S.C. § 1320a-7b(f)) or any other government healthcare program or human clinical research, including under 21 U.S.C. § 335a or any
PRE 14A
ixln91rj 74ox
10 Apr 23
Preliminary proxy
4:31pm
8-K
EX-99.1
q9p8sm4frt67r4r v3t9
11 Jul 22
SQZ Biotechnologies Appoints Micah Zajic as Chief Financial Officer
4:49pm
S-3
EX-1.2
fu54idplc2vj9828f
12 Nov 21
Shelf registration
12:00am
8-K
EX-99.1
l7xt 0e19av
1 Jul 21
SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience
5:07pm
DEF 14A
408957iweyz6uhdg
26 Apr 21
Definitive proxy
5:00pm
10-K
vvqswd7p
18 Mar 21
Annual report
6:31am
424B4
ftb3wfi
12 Feb 21
Prospectus supplement with pricing info
5:10pm
DRS
46dc6 3muv
1 Feb 21
Draft registration statement
12:00am
10-Q
h1g2bnsrlpyj9px49kjy
10 Dec 20
Quarterly report
4:46pm